CEO looks to take China Nuokang private after difficult 2011
This article was originally published in Scrip
Executive Summary
The Chinese firm China Nuokang Bio-Pharmaceutical has received a preliminary management buyout proposal from its chairman and CEO after slumping to a net loss last year during a challenging business period.